Fmoc-Gln(Trt)-OPfp

Fmoc-Gln(Trt)-OPfp is an Fmoc-protected glutamine derivative in which the side-chain amide is protected with a Trt (trityl) group and the carboxylate is present as an OPfp ester (pentafluorophenyl ester). The molecule combines a chiral amino acid core with an N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group on the α-amine and a sterically robust Trt-protected side-chain amide, enabling controlled peptide coupling while suppressing undesired side reactions. The OPfp ester introduces a highly activated carboxylate that can participate in efficient acyl transfer chemistry under peptide synthesis conditions, while the Fmoc group supports orthogonal N-deprotection strategies for stepwise chain assembly. The resulting reactivity profile makes Fmoc-Gln(Trt)-OPfp a chiral, protected amino acid building block and peptide-coupling intermediate suitable for downstream conversion into glutamine-containing peptide sequences and related amide-linked derivatives.

1. Peptide Synthesis

Fmoc-Gln(Trt)-OPfp is applied in peptide building-block preparation and solid-phase peptide synthesis workflows where glutamine residues require orthogonal protection of both the α-amino group and the side-chain amide. The Fmoc carbamate on the α-amine enables iterative N-terminal deprotection and re-coupling, while the Trt group on the side-chain amide helps maintain chemoselectivity by reducing side-chain participation during chain elongation. The OPfp ester activates the carboxylate for acyl transfer, supporting peptide coupling chemistry that forms the backbone amide bond with reduced risk of carboxylate deactivation. The protected glutamine side chain can be carried through multiple steps and then unmasked under standard deprotection conditions to yield glutamine-containing peptides for biochemical research and peptide material generation.

2. Protected Amino Acids

Fmoc-Gln(Trt)-OPfp supports protected amino acid synthesis strategies that require stable side-chain protection compatible with peptide assembly and later functional unmasking. The Trt-protected side-chain amide is structurally suited to withstand coupling conditions that might otherwise lead to side-chain acylation or polymerization, while the Fmoc group provides a controlled handle for N-terminal deprotection cycles. The OPfp ester functions as a reactive carboxylate derivative for forming amide linkages without exposing the free carboxylic acid during intermediate handling. Downstream use commonly includes conversion into glutamine-containing peptide fragments, peptidomimetic precursors, and amide-linked intermediates where orthogonal deprotection is required to reveal the native glutamine functionality.

3. Peptidomimetics And SAR

Fmoc-Gln(Trt)-OPfp is utilized in peptidomimetic construction and structure-activity relationship studies where glutamine-like side-chain amide geometry and hydrogen-bonding capacity must be preserved through synthetic elaboration. The side-chain Trt protection maintains the amide as a non-reactive substituent during scaffold assembly, allowing incorporation into constrained analogs, backbone-modified peptides, or fragment-based coupling sequences. The OPfp ester activation can be leveraged to generate amide-linked intermediates that feed into SAR libraries, including analogs where the glutamine residue is retained for binding-site recognition or replaced in systematic variation. The Fmoc-protected α-amino functionality further enables controlled assembly of defined sequences and facilitates subsequent deprotection to expose the side-chain amide for molecular recognition studies.

4. Chemical Biology Labeling

Fmoc-Gln(Trt)-OPfp can be applied to chemical biology workflows that require glutamine-containing peptide conjugates for probing protein surfaces, mapping interaction interfaces, or generating defined amide-linked probes. The protected side-chain amide and Fmoc-controlled α-amino group allow synthesis of conjugatable peptide segments with minimized side reactions, while the activated OPfp ester supports formation of stable amide bonds to linkers or capture handles. The ability to carry the glutamine functionality through assembly and then unmask it supports downstream conjugation chemistry that depends on maintaining hydrogen-bonding and polarity features. The resulting glutamine-bearing peptide conjugates can serve as research reagents for biomolecular interaction studies and for generating defined substrates or ligands used in biochemical assays.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-Gln(Trt)-OPfp is relevant to pharmaceutical manufacturing and process chemistry as a protected glutamine derivative that can be integrated into scalable peptide and peptide-analog intermediate preparation. The Fmoc/Trt orthogonal protection scheme supports robust stepwise processing, where N-terminal deprotection and side-chain unmasking can be scheduled to match manufacturing sequence design. The OPfp ester form provides a controllable activated carboxylate for coupling steps, which can be advantageous for reproducible formation of amide bonds during intermediate manufacture. Downstream, the compound can be converted into glutamine-containing peptide intermediates used in active pharmaceutical ingredient (API) synthesis routes or in the production of peptide-based materials requiring defined stereochemistry and protected-group integrity.

6. Analytical Research Standards

Fmoc-Gln(Trt)-OPfp is suitable for analytical research applications where protected amino acid derivatives are needed as reference materials, coupling controls, or structural standards for method development. The presence of Fmoc and Trt groups provides distinct, easily tracked protecting-group signatures, while the OPfp ester enables characterization of activated carboxylate intermediates and their consumption during peptide coupling. The defined stereochemistry of the glutamine backbone supports consistent mass-based and chromatographic behavior when monitoring derivatization steps or verifying intermediate identity. The compound can be employed in analytical workflows that assess peptide synthesis performance, protect-group stability, and impurity profiles associated with glutamine-containing building blocks, supporting reliable interpretation of peptide assembly processes.

1. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

5. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis